Mycobacteriosis has long been recognized as a disease of companion psittacine birds. In this review, the signalment, clinical signs of disease, and diagnosis of mycobacteriosis in psittacine birds are presented. Although treatment of birds with mycobacteriosis is controversial, therapeutic protocols for use in psittacine birds have been developed based on protocols used in humans. Results of recent studies indicate that mycobacteriosis in psittacine birds is unlikely to represent a significant health risk for humans. However, the potential for zoonotic disease must be considered, especially if persons who are immunocompromised are in contact with an infected bird.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 21 • No. 3